Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Modified Release Oral Formulation”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Large-scale testing (Phase 3)Study completedNCT00865137
What this trial is testing

An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 27
Early research (Phase 1)Ended earlyNCT00449709
What this trial is testing

Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects

Who this might be right for
Obstetric Labour, PrematurePremature Ejaculation
GlaxoSmithKline 36
Testing effectiveness (Phase 2)Study completedNCT01786512
What this trial is testing

COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure

Who this might be right for
Modified Release Oral FormulationLeft Ventricular Systolic DysfunctionChronic Heart Failure+4 more
Cytokinetics 544
Early research (Phase 1)Study completedNCT01731327
What this trial is testing

Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy Volunteers

Who this might be right for
Healthy
Pfizer 20
Early research (Phase 1)Study completedNCT02206607
What this trial is testing

Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 39
Early research (Phase 1)Study completedNCT02273531
What this trial is testing

Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 24
Early research (Phase 1)Study completedNCT02201511
What this trial is testing

A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions

Who this might be right for
Healthy
Pfizer 12
Early research (Phase 1)Study completedNCT04124653
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy Participants

Who this might be right for
Healthy Participants
Pfizer 44
Early research (Phase 1)Study completedNCT01646294
What this trial is testing

Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted Conditions

Who this might be right for
Pharmacokinetics of YM178Healthy Subjects
Astellas Pharma Europe B.V. 34
Early research (Phase 1)Study completedNCT02319057
What this trial is testing

Pharmacokinetic Study of Single Doses of ORM-12741

Who this might be right for
Healthy
Orion Corporation, Orion Pharma 23
Early research (Phase 1)Study completedNCT04856358
What this trial is testing

Evaluate How Well Single and Multiple Doses of GLPG3121-modified Release Formulation Are Tolerated in Healthy, Adult Subjects

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 50
Early research (Phase 1)Study completedNCT05816356
What this trial is testing

To Study the Oral Bioavailability of a New Combination Formation of Decitabine and Tetrahydrouridine in Healthy Males

Who this might be right for
Healthy
EpiDestiny, Inc. 10
Early research (Phase 1)Study completedNCT04580797
What this trial is testing

Clinical Study to Evaluate Pharmacokinetics and Safety of PF-06700841 After Single and Multiple Oral Doses as Modified Release Formulations

Who this might be right for
Healthy Participants
Pfizer 36
Early research (Phase 1)Study completedNCT06291285
What this trial is testing

Test How Either a Capsule or a Tablet With NDec (Decitabine and Tetrahydrouridine) Works in the Body of Healthy People

Who this might be right for
Healthy Volunteers
Novo Nordisk A/S 44